Breaking News Instant updates and real-time market news.

GH

Guardant Health

$74.00

-3.54 (-4.57%)

07:12
04/16/19
04/16
07:12
04/16/19
07:12

Guardant Health initiated with a Buy at Canaccord

Canaccord analyst Mark Massaro initiated Guardant Health with a Buy rating and $90 price target, saying the company is accelerating its mission to conquer cancer globally and views Guardant as the leader in liquid biopsy cancer testing. Guardant expects to submit G360 to the FDA for break-through device approval by mid-2019 and expects FDA approval by the end of 2019 or early 2020, which he thinks will reduce push back from the remaining 40% of U.S.-based oncologists who have not yet ordered.

  • 05

    Jun

GH Guardant Health
$74.00

-3.54 (-4.57%)

04/16/19
ADAM
04/16/19
INITIATION
Target $90
ADAM
Buy
Guardant Health initiated with a Buy at Canaccord
Canaccord initiated Guardant Health with a Buy and $90 price target.
04/10/19
BOFA
04/10/19
UPGRADE
Target $84
BOFA
Buy
Guardant Health upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Derik de Bruin upgraded Guardant Health to Buy from Neutral and raised its price target to $84 from $81 citing growth potential despite the recent run in shares. de Bruin aid Guardant Health is a leader in liquid biopsy-based cancer testing and said expectations remain reasonable following the lock-up expiration, LUNAR-1 data release, G360 expanded coverage, and a review of the liquid-biopsy testing market.
04/03/19
COWN
04/03/19
NO CHANGE
Target $70
COWN
Outperform
Guardant Health price target raised to $70 from $40 at Cowen
Cowen analyst Doug Schenkel raised his 2019 revenue forecast for Guardant Health by about $14M to $133.8M, which he noted is consistent with management guidance and consensus. While he sees some instances where he believes some expectations for Guardant "have got a bit ahead of themselves," Schenkel keeps an Outperform rating on the shares and raised his price target to $70 from $40, citing his view that the company has established itself as "the leader in comprehensive liquid biopsy testing for metastatic cancer patients."
04/01/19
JPMS
04/01/19
NO CHANGE
Target $85
JPMS
Overweight
JPMorgan 'encouraged on several fronts' after Guardant Health meetings
JPMorgan analyst Tycho Peterson says he walked away from investor meetings with Guardant Health management "encouraged on several fronts." The analyst sees continued progress on reimbursement via the Palmetto draft local coverage determination and highlights management's confidence in driving volumes via ramping adoption. Guardant offers an attractive sales growth profile driven by continued traction in G360/OMNI and "steady momentum" in biopharma partnerships, as well as a "relatively clear line-of-sight" to expanded clinical reimbursement, Peterson tells investors in a research note. He continues to view Guardant Health as a "best-in-class asset in the attractive liquid biopsy space." Furthermore, the recent 20% share pullback from all-time highs heading into the lock-up expiration has resulted in renewed investor interest, says the analyst. He reiterates an Overweight rating on Guardant Health with an $85 price target.

TODAY'S FREE FLY STORIES

F

Ford

$9.41

-0.17 (-1.77%)

, GM

General Motors

$39.12

-0.61 (-1.54%)

14:10
04/25/19
04/25
14:10
04/25/19
14:10
Earnings
Fly Intel: What to watch in auto sector earnings reports »

Ford (F) is scheduled to…

F

Ford

$9.41

-0.17 (-1.77%)

GM

General Motors

$39.12

-0.61 (-1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 05

    Jun

  • 24

    Jul

  • 23

    Oct

CPRI

Capri Holdings

$44.85

-1.26 (-2.73%)

14:05
04/25/19
04/25
14:05
04/25/19
14:05
Options
Capri Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:00
04/25/19
04/25
14:00
04/25/19
14:00
General news
Treasury Action: the market has eroded slightly »

Treasury Action: the…

CLB

Core Laboratories

$66.31

-6.595 (-9.05%)

13:51
04/25/19
04/25
13:51
04/25/19
13:51
Recommendations
Core Laboratories analyst commentary at Stifel »

Core Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

AVP

Avon Products

$3.13

0.175 (5.92%)

13:49
04/25/19
04/25
13:49
04/25/19
13:49
Periodicals
Natura said to be in advanced talks to acquire Avon, Valor Economico says »

Natura is in advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

DLPH

Delphi Technologies

$22.60

-2 (-8.13%)

13:45
04/25/19
04/25
13:45
04/25/19
13:45
Options
Delphi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

ADTN

Adtran

$17.39

-0.38 (-2.14%)

13:40
04/25/19
04/25
13:40
04/25/19
13:40
Earnings
Adtran VP Roger Shannon sold over $100K in company shares »

Adtran VP Roger Shannon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

AVYA

Avaya

$20.22

0.895 (4.63%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Periodicals
Mitel offering to combine with Avaya in stock deal worth over $2B, WSJ says »

Avaya is in talks to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

TECK.B

Teck Corp.

$0.00

(0.00%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Conference/Events
Teck Corp. management to meet with B.Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

CWT

California Water Service

$49.43

-0.57 (-1.14%)

13:32
04/25/19
04/25
13:32
04/25/19
13:32
Upgrade
California Water Service rating change  »

California Water Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:30
04/25/19
04/25
13:30
04/25/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Bausch Health »

Bausch Health trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

AVYA

Avaya

$20.20

0.875 (4.53%)

13:28
04/25/19
04/25
13:28
04/25/19
13:28
Periodicals
Mitel offers to combine with Avaya in stock deal, WSJ says »

Mitel's bid values…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

CLVS

Clovis

$19.43

-0.4 (-2.02%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 31

    May

AGN

Allergan

$140.66

0.98 (0.70%)

, TEVA

Teva

$15.07

0.065 (0.43%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Conference/Events
Piper Jaffray specialty pharma analysts to hold analyst/industry conference call »

Specialty Pharmaceuticals…

AGN

Allergan

$140.66

0.98 (0.70%)

TEVA

Teva

$15.07

0.065 (0.43%)

ALDR

Alder Biopharmaceuticals

$13.95

0.29 (2.12%)

AMGN

Amgen

$179.82

1.56 (0.88%)

BHVN

Biohaven Pharmaceutical

$62.30

-0.855 (-1.35%)

LLY

Eli Lilly

$117.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 21

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

ZM

Zoom Video

$64.49

1.175 (1.86%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Zoom, Slack announce new partnership »

Zoom and Slack have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Bausch Health announces FDA approval of Duobrii for plaque psoriasis »

Bausch Health and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
04/25/19
04/25
13:17
04/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$382.62

7.3 (1.95%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Recommendations
Boeing analyst commentary at Bernstein »

Bernstein says Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    May

  • 05

    Jun

BA

Boeing

$382.62

7.3 (1.95%)

13:15
04/25/19
04/25
13:15
04/25/19
13:15
Periodicals
FAA targeting May 23 for meeting over 737 MAX changes, Aviation Week says »

The FAA is targeting May…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    May

  • 05

    Jun

13:12
04/25/19
04/25
13:12
04/25/19
13:12
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:12
04/25/19
04/25
13:12
04/25/19
13:12
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

RSG

Republic Services

$79.29

-0.01 (-0.01%)

13:10
04/25/19
04/25
13:10
04/25/19
13:10
Options
Upside call buys in Republic Services ahead of earnings »

Upside call buys in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    May

  • 17

    May

  • 05

    Jun

LUV

Southwest

$54.00

1.08 (2.04%)

13:06
04/25/19
04/25
13:06
04/25/19
13:06
Hot Stocks
Breaking Hot Stocks news story on Southwest »

Southwest continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 13

    Nov

LUV

Southwest

$54.00

1.08 (2.04%)

, BA

Boeing

$379.25

3.93 (1.05%)

13:06
04/25/19
04/25
13:06
04/25/19
13:06
Hot Stocks
Southwest expects FY19 capacity to increase 2%-3% y-o-y »

Says continues to have…

LUV

Southwest

$54.00

1.08 (2.04%)

BA

Boeing

$379.25

3.93 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 15

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.